Antenatal screening for Down's syndrome.
?
['Biomarkers', 'Cost-Benefit Analysis', 'Decision Trees', 'Down Syndrome/*diagnosis/genetics/metabolism/prevention & control', 'Health Services Accessibility', 'Humans', 'Mass Screening/economics/*methods', 'Prenatal Diagnosis/economics/*methods', 'Quality Assurance, Health Care', 'Reproducibility of Results', 'Technology Assessment, Biomedical']